Improved glucose tolerance with DPPIV inhibition requires β‐cell SENP1 amplification of glucose‐stimulated insulin secretion
Abstract Pancreatic islet insulin secretion is amplified by both metabolic and receptor‐mediated signaling pathways. The incretin‐mimetic and DPPIV inhibitor anti‐diabetic drugs increase insulin secretion, but in humans this can be variable both in vitro and in vivo. We examined the correlation of G...
Main Authors: | Mourad Ferdaoussi, Nancy Smith, Haopeng Lin, Austin Bautista, Aliya F. Spigelman, James Lyon, XiaoQing Dai, Jocelyn E. Manning Fox, Patrick E. MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Physiological Reports |
Online Access: | https://doi.org/10.14814/phy2.14420 |
Similar Items
-
A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding
by: Haopeng Lin, et al.
Published: (2024-01-01) -
PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets
by: Jelena Kolic, et al.
Published: (2016-07-01) -
SENP2 knockdown in human adipocytes reduces glucose metabolism and lipid accumulation, while increases lipid oxidation
by: Solveig A. Krapf, et al.
Published: (2023-06-01) -
K(ATP)-channels and glucose-regulated glucagon secretion.
by: Rorsman, P, et al.
Published: (2008) -
Discovery of a Dual SENP1 and SENP2 Inhibitor
by: Michael Brand, et al.
Published: (2022-10-01)